Lung Cancer Online
Home Care Support Info Treatment Effects Tests Surviving Sites MedLit

 home > treatment > agents & regimens > recentin (AZD2171)

Recentin (AZD2171): AstraZeneca : vascular endothelial growth factor (VEGF) signaling inhibitor

Recentin (AZD2171) - 2006 ASCO Annual Meeting Abstracts: 3054, 3034, 3017

Recentin (AZD2171) - Recent MEDLINE Abstracts (PubMed)

Recentin (AZD2171) - Clinical Trials (ClinicalTrials.gov)

 


 

Feedback / Queries Disclaimer Advocacy - You Can Help

Copyright © 1999-2006, Lung Cancer Online Foundation
Last modified: 18-Feb-2009
Karen Parles, MLS Editor